D-0304-2025 Class III Terminated

Recalled by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — La Vergne, TN

Recall Details

Product Type
Drugs
Report Date
April 9, 2025
Initiation Date
March 4, 2025
Termination Date
February 23, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
224 cartons

Product Description

Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.

Reason for Recall

Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.

Distribution Pattern

Nationwide in the USA

Code Information

Lot# T05393, Exp. Date: 09/30/2025